Sign in

CIK 0000811641

  • Non-accelerated filer
  • Smaller reporting company

IMMUCELL CORP /DE/

Sign in to watch
Ticker
ICCC
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
010382980
Phone
+1 207-878-2770
Business address
56 EVERGREEN DR, PORTLAND, ME, 04103
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Grant or award Director acquired 3,845 shares (grant or award)
  5. 4 Grant or award Director acquired 4,742 shares (grant or award)
  6. 4 Open-market buy Director bought 2,000 shares at $4.00 ($8,000)
  7. 4 Open-market buy Director bought 4,600 shares at $4.28 ($19,688)
  8. 4 Open-market buy Director bought 5,130 shares at $4.98 ($25,547)
  9. 4 Derivatives Options or other derivatives
  10. 4 Grant or award Director acquired 2,724 shares (grant or award)
  11. 4 Grant or award Director acquired 4,269 shares (grant or award)
  12. 4 Option exercise President & CEO acquired 47,500 shares (option exercise)
  13. 4 Option exercise Vice President and CSO acquired 47,500 shares (option exercise)
  14. 4 Open-market buy Director bought 3,000 shares at $6.67 ($20,010)
  15. 4 Returned to the company Director returned 930 shares (to the company)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 4 of 13 · 256 filings